Retour
62
Fourchette du Jour
26,28 €
27,48 €
Fourchette 52 Semaines
9,90 €
34,29 €
Volume
1 383 085
Moyenne 50J / 200J
30,25 €
/
24,06 €
Clôture Précédente
27,62 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -6,7 | 0,3 |
| P/B | 3,2 | 2,9 |
| ROE % | -49,2 | 3,7 |
| Net Margin % | -483,6 | 3,8 |
| Rev Growth 5Y % | 121,1 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
43,10 €
+58.5%
Low: 34,00 €
High: 50,00 €
BPA Prévisionnel
-3,82 €
CA Est.
75 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
4,62 €
1,45 € – 10,66 €
|
1,3 B | 4 |
| FY2029 |
3,04 €
0,95 € – 7,02 €
|
1 B | 4 |
| FY2028 |
0,81 €
-3,32 € – 5,27 €
|
690 M | 11 |
Points Clés
Revenue grew 121,13% annually over 5 years — strong growth
Debt/Equity of 0,07 — conservative balance sheet
Negative free cash flow of -276,89M
PEG of 0,46 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 23238,80%
Capital efficient — spends only 0,70% of revenue on capex
Croissance
Revenue Growth (5Y)
121,13%
Revenue (1Y)23359,93%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-49,16%
ROIC-35,26%
Net Margin-483,57%
Op. Margin-512,91%
Sécurité
Debt / Equity
0,07
Current Ratio12,65
Interest Coverage-73,44
Valorisation
P/E Ratio
-6,73
P/B Ratio3,19
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 23359,93% | Revenue Growth (3Y) | 1402,11% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 121,13% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 70,85M | Net Income (TTM) | -342,60M |
| ROE | -49,16% | ROA | -38,09% |
| Gross Margin | 98,36% | Operating Margin | -512,91% |
| Net Margin | -483,57% | Free Cash Flow (TTM) | -276,89M |
| ROIC | -35,26% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 12,65 |
| Interest Coverage | -73,44 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -6,73 | P/B Ratio | 3,19 |
| P/S Ratio | 32,56 | PEG Ratio | 0,46 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,31B | Enterprise Value | 2,15B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 70,85M | 302 000,0 | 314 000,0 | 1,77M | 2,96M |
| Net Income | -342,60M | -269,95M | -237,73M | -129,87M | -79,41M |
| EPS (Diluted) | -3,32 | -3,98 | -5,31 | -3,91 | -6,66 |
| Gross Profit | 69,69M | 302 000,0 | 314 000,0 | 1,77M | 2,96M |
| Operating Income | -363,40M | -299,04M | -254,45M | -134,30M | -79,73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 899,42M | 742,40M | 490,42M | 435,09M | 203,71M |
| Total Liabilities | 177,25M | 70,76M | 48,40M | 40,03M | 15,99M |
| Shareholders' Equity | 722,17M | 671,64M | 442,02M | 395,06M | 187,72M |
| Total Debt | 50,69M | 21,10M | 21,05M | 5,26M | 520 000,0 |
| Cash & Equivalents | 212,38M | 99,59M | 102,83M | 155,58M | 42,30M |
| Current Assets | 894,23M | 738,46M | 486,48M | 424,55M | 200,16M |
| Current Liabilities | 70,70M | 47,87M | 26,64M | 33,35M | 13,64M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#25 of 146
Activité Récente
Entré
Full Throttle
Mar 24, 2026